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Background: Although Angio-Seal™ vascular closure device (VCD) (St. Jude Medical, St. Paul, MN) is effective in reducing time to hemostasis 
following percutaneous coronary intervention (PCI), there are safety concerns. 
Methods: From March 2005 to June 2009, 13,379 consecutive patients underwent PCI using femoral artery approach. We retrospectively 
evaluated length of hospital stay, rate of local vascular complications and all-cause mortality in 2 groups: Angio-Seal VCD (1,103 patients, 8%) and 
manual compression or mechanical compression devices (12,276 patients, 92%). 
Results: Length of hospital stay was shorter with Angio-Seal VCD (1.8 days vs. 2.3 days, p<0.001). Incidence of any vascular complication was not 
different between the 2 groups (1.1% vs. 1.9%, p=0.053). After adjusting for baseline differences, multivariate logistic regression analysis showed 
no difference in rate of vascular complications or 1-year all-cause mortality between the 2 groups. Conclusions Following PCI, Angio-Seal VCD may 
shorten length of hospital stay, but doesn’t increase vascular complications or 1-year all-cause mortality when compared to manual compression or 
mechanical compression devices. 
Angio-Seal VCD Versus Manual Compression or Mechanical Compression Devices
Type of Closure
P-valueCharacteristic Overall Seal Manual/Mechanical
No of Patients 13,379 1,103 (8.2%) 12,276 (91.8%)
Baseline Characteristics
Age - mean ± SD years 66.1±12.30 65.3±12.48 66.1±12.28 0.019
Age ≥70 years - no. (%) 5,609 (41.9%) 434 (39.4%) 5,175 (42.2%) 0.070
Women - no. (%) 4,964 (37.1%) 401 (36.4%) 4,563 (37.2%) 0.592
Renal failure - no. (%) 603 (4.5%) 53 (4.8%) 550 (4.5%) 0.618
PVD - no. (%) 1,736 (13.0%) 94 (8.5%) 1,642 (13.4%) <0.001
BMI - mean ± SD kg/m2 30.0±6.57 30.4±6.96 30.0±6.53 0.087
GP IIbIIIa - no. (%) 3,318 (24.8%) 104 (9.4%) 3,214 (26.2%) <0.001
Endpoint
Length of hospital stay - mean ± SD days 2.2 ± 3.72 1.8 ± 2.83 2.3 ± 3.78 <0.001
Any vascular complication - no (%) 246 (1.8%) 12 (1.1%) 234 (1.9%) 0.053
All-cause one-year mortality - no. (%) 581 (4.3%) 35 (3.2%) 546 (4.5%) 0.047
Endpoint Adjusted OR (95%CI) for Manual/Mechanical vs. Seal
Any vascular complication 0.67 (0.35-1.16) 0.183
All-cause one-year mortality 0.75 (0.51-1.06) 0.115
Differences in patients’ demographic and clinical characteristics were compared across the two closure groups with Wilcoxon rank sum test for continuous variables 
and chi-square test for categorical variables.
Abbreviations: BMI=body mass index; OR=odds ratio; PCI=percutaneous coronary intervention; PVD=peripheral vascular disease.
